Development and assessment of the efficacy and safety of human lung-targeting liposomal methylprednisolone crosslinked with nanobody
Glucocorticoid (GC) hormone has been commonly used to treat systemic inflammation and immune disorders. However, the side effects associated with long-term use of high-dose GC hormone limit its clinical application seriously. GC hormone that can specifically target the lung might decrease the effect...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2021-01-01
|
| coleção: | Drug Delivery |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.1080/10717544.2021.1921073 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
